Home
Par Drugs & Chemicals Ltd EPS
Par Drugs & Chemicals Ltd
NSE: PAR
EPS
Key Highlights
- The Earning per Share of Par Drugs & Chemicals Ltd is ₹ 7.87 as of 28 Nov 25 .
- The earning per share of Par Drugs & Chemicals Ltd changed from ₹ 2.01 to ₹ 3.36 over 10 quarters. This represents a CAGR of 22.82% .
Historical Earning per Share of Par Drugs & Chemicals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Par Drugs & Chemicals Ltd
Company Fundamentals for Par Drugs & Chemicals Ltd
Market Price of Par Drugs & Chemicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Nov 2025 | 89.53 |
| 27 Nov 2025 | 89.69 |
| 26 Nov 2025 | 90.56 |
| 25 Nov 2025 | 89.97 |
| 24 Nov 2025 | 91.6 |
| 21 Nov 2025 | 92.23 |
| 20 Nov 2025 | 92.65 |
| 19 Nov 2025 | 92.83 |
| 18 Nov 2025 | 94.07 |
| 17 Nov 2025 | 94.11 |
SWOT Analysis Of Par Drugs & Chemicals Ltd
BlinkX Score for Par Drugs & Chemicals Ltd
Asset Value vs Market Value of Par Drugs & Chemicals Ltd
Market Value
₹ 110
Asset Value
Value addition
1.0 X
₹ 55
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Par Drugs & Chemicals Ltd | 110.16 | 7.87 |
Sun Pharmaceutical Industries Ltd | 434160 | 48.13 |
Divis Laboratories Ltd | 172288 | 93.61 |
Torrent Pharmaceuticals Ltd | 126434 | 64.02 |
Cipla Ltd | 123149 | 67.36 |
Dr Reddys Laboratories Ltd | 104369 | 69.16 |
| Company | |
|---|---|
| Par Drugs & Chemicals Ltd | 110.16 |
| Sun Pharmaceutical Industries Ltd | 434160 |
| Divis Laboratories Ltd | 172288 |
| Torrent Pharmaceuticals Ltd | 126434 |
| Cipla Ltd | 123149 |
| Dr Reddys Laboratories Ltd | 104369 |
Historical Market Cap of Par Drugs & Chemicals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Par Drugs & Chemicals Ltd
Historical Revenue of Par Drugs & Chemicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Par Drugs & Chemicals Ltd
Historical EBITDA of Par Drugs & Chemicals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Par Drugs & Chemicals Ltd
Historical Net Profit of Par Drugs & Chemicals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Par Drugs & Chemicals Ltd
Dividend Payout Over Time
Par Drugs & Chemicals Ltd News Hub
Par Drugs & Chemicals AGM scheduled
Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be he
Read more
19 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024
Read more
10 Aug 24
Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter
Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as ag
Read more
05 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 22 October 202
Read more
14 Oct 24
